Literature DB >> 18563875

How do azoles inhibit cytochrome P450 enzymes? A density functional study.

Philip R Balding1, Cristina S Porro, Kirsty J McLean, Michael J Sutcliffe, Jean-Didier Maréchal, Andrew W Munro, Sam P de Visser.   

Abstract

To examine how azole inhibitors interact with the heme active site of the cytochrome P450 enzymes, we have performed a series of density functional theory studies on azole binding. These are the first density functional studies on azole interactions with a heme center and give fundamental insight into how azoles inhibit the catalytic function of P450 enzymes. Since azoles come in many varieties, we tested three typical azole motifs representing a broad range of azole and azole-type inhibitors: methylimidazolate, methyltriazolate, and pyridine. These structural motifs represent typical azoles, such as econazole, fluconazole, and metyrapone. The calculations show that azole binding is a stepwise mechanism whereby first the water molecule from the resting state of P450 is released from the sixth binding site of the heme to create a pentacoordinated active site followed by coordination of the azole nitrogen to the heme iron. This process leads to the breaking of a hydrogen bond between the resting state water molecule and the approaching inhibitor molecule. Although, formally, the water molecule is released in the first step of the reaction mechanism and a pentacoordinated heme is created, this does not lead to an observed spin state crossing. Thus, we show that release of a water molecule from the resting state of P450 enzymes to create a pentacoordinated heme will lead to a doublet to quartet spin state crossing at an Fe-OH(2) distance of approximately 3.0 A, while the azole substitution process takes place at shorter distances. Azoles bind heme with significantly stronger binding energies than a water molecule, so that these inhibitors block the catalytic cycle of the enzyme and prevent oxygen binding and the catalysis of substrate oxidation. Perturbations within the active site (e.g., a polarized environment) have little effect on the relative energies of azole binding. Studies with an extra hydrogen-bonded ethanol molecule in the model, mimicking the active site of the CYP121 P450, show that the resting state and azole binding structures are close in energy, which may lead to chemical equilibrium between the two structures, as indeed observed with recent protein structural studies that have demonstrated two distinct azole binding mechanisms to P450 heme.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563875     DOI: 10.1021/jp802087w

Source DB:  PubMed          Journal:  J Phys Chem A        ISSN: 1089-5639            Impact factor:   2.781


  15 in total

1.  Polyunsaturated fatty acid metabolites: biosynthesis in Leishmania and role in parasite/host interaction.

Authors:  Lucie Paloque; Teresa Perez-Berezo; Anne Abot; Jessica Dalloux-Chioccioli; Sandra Bourgeade-Delmas; Pauline Le Faouder; Julien Pujo; Marie-Ange Teste; Jean-Marie François; Nils Helge Schebb; Malwina Mainka; Corinne Rolland; Catherine Blanpied; Gilles Dietrich; Justine Bertrand-Michel; Céline Deraison; Alexis Valentin; Nicolas Cenac
Journal:  J Lipid Res       Date:  2019-01-09       Impact factor: 5.922

Review 2.  The Mycobacterium tuberculosis cytochrome P450 system.

Authors:  Hugues Ouellet; Jonathan B Johnston; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2009-07-25       Impact factor: 4.013

3.  Cross-linking of dicyclotyrosine by the cytochrome P450 enzyme CYP121 from Mycobacterium tuberculosis proceeds through a catalytic shunt pathway.

Authors:  Kednerlin Dornevil; Ian Davis; Andrew J Fielding; James R Terrell; Li Ma; Aimin Liu
Journal:  J Biol Chem       Date:  2017-06-30       Impact factor: 5.157

4.  Unravelling novel synergies between organometallic and biological partners: a quantum mechanics/molecular mechanics study of an artificial metalloenzyme.

Authors:  Elisabeth Ortega-Carrasco; Agustí Lledós; Jean-Didier Maréchal
Journal:  J R Soc Interface       Date:  2014-07-06       Impact factor: 4.118

Review 5.  Interactions of cytochrome P450s with their ligands.

Authors:  Kip P Conner; Caleb M Woods; William M Atkins
Journal:  Arch Biochem Biophys       Date:  2010-10-19       Impact factor: 4.013

6.  Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain.

Authors:  Natalia Mast; Casey Charvet; Irina A Pikuleva; C David Stout
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

7.  A New Variant of Mutational and Polymorphic Signatures in the ERG11 Gene of Fluconazole-Resistant Candida albicans.

Authors:  Arome Solomon Odiba; Olanrewaju Ayodeji Durojaye; Ifeoma Maureen Ezeonu; Anthony Christian Mgbeahuruike; Bennett Chima Nwanguma
Journal:  Infect Drug Resist       Date:  2022-06-17       Impact factor: 4.177

8.  Biochemical and structural characterization of CYP124: a methyl-branched lipid omega-hydroxylase from Mycobacterium tuberculosis.

Authors:  Jonathan B Johnston; Petrea M Kells; Larissa M Podust; Paul R Ortiz de Montellano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-20       Impact factor: 11.205

9.  Arene activation by a nonheme iron(III)-hydroperoxo complex: pathways leading to phenol and ketone products.

Authors:  Abayomi S Faponle; Frédéric Banse; Sam P de Visser
Journal:  J Biol Inorg Chem       Date:  2016-04-20       Impact factor: 3.358

10.  Probing the origins of aromatase inhibitory activity of disubstituted coumarins via QSAR and molecular docking.

Authors:  Apilak Worachartcheewan; Naravut Suvannang; Supaluk Prachayasittikul; Virapong Prachayasittikul; Chanin Nantasenamat
Journal:  EXCLI J       Date:  2014-12-08       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.